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Background: Pyocyanin (PCN), an extracellular product of Pseudomonas aeruginosa and a blue redox active
secondary metabolite, plays an important role in invasive pulmonary infection. However, the detailed inflammatory
response triggered by PCN infection in inflammatory cells (particularly macrophages), if present, remains to be
clarified. To investigate the effects of PCN on macrophages, the ability of PCN to induce inflammation reaction and
the signaling pathway for IL-8 release in PCN-induced differentiated U937 cells were examined.
Results: It was found that PCN increased IL-8 release and mRNA expression in Phorbol 12-myristate 13-acetate (PMA)
differentiated U937 cells in both a concentration- and time-dependent manner by reverse transcription-polymerase
chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). P38 and ERK MAPKs were activated after
10 min of induction with PCN and their levels returned to baselines after 30 min by Western blotting. It was also found
that within 10 min of PCN incubation, the level of p-I-κBα in the cytosol was increased, which returned to baseline level
after 60 min. Meanwhile, the level of p-p65 was increased in the nuclear extract and cytosol, and maintained high in
total cell lysates. The results were further confirmed by the observation that p38, ERK1/2 and NF-κB inhibitors inhibited
PCN-induced NF-κB activation and attenuated PCN-induced IL-8 expression in U937 cells as a function of their
concentrations. Moreover, it was shown that PCN induced oxidative stress in U937 cells and N-acetyl cysteine,
an antioxidant, was able to inhibit PCN-induced IL-8 protein expression.
Conclusions: It is concluded that PCN induces IL-8 secretion and mRNA expression in PMA-differentiated U937
cells in a concentration- and time- dependent manner. Furthermore, p38 and ERK MAPKs and NF-κΒ signaling
pathways may be involved in the expression of IL-8 in PCN-incubated PMA-differentiated U937 cells.
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Pseudomonas aeruginosa (P. aeruginosa), an opportunistic
pathogen, causes infections associated with high inci-
dences of morbidity and mortality in immunocomprom-
ised hosts. P. aeruginosa colonizes the lower respiratory
tract in patients resulting in bronchiectasis, cystic fibrosis,
and chronic obstructive pulmonary disease [1-3]. The
pathogen has a broad host range, which produces a large* Correspondence: cws1964@aliyun.com; chenbaiyi63@163.com
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stated.number of extracellular products including elastase and
alkaline protease, LasA protease, hemolysin, rhamnolipid,
and pyocyanin (PCN). These extracellular products
alter host cell function and may contribute to disease
pathogenesis.
Among recognized virulence factors, the redox-active
phenazine PCN, a blue redox active secondary metabol-
ite, plays an important role in invasive pulmonary infec-
tion. Early studies have shown that PCN causes multiple
effects on human cells, such as inhibition of cell respiration,
ciliary function, epidermal cell growth, and prostacyclin re-
lease. Furthermore, PCN alters calcium homeostasis, caus-
ing damage to human cells. Recent studies have confirmed
that PCN can alter the host’s immune response and in-
crease IL-1 and TNF-α secretion induced by monocytes.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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to clear out pathogens, extend the time limit or prevent the
infection of bacterial clearance, and increase secretion of
inflammatory mediators in the body that can produce ad-
verse reactions. Studies have also shown that PCN and
its precursor, promethazine-1-carboxylic acid, change
the host’s immune response by adjusting the RANTES
[4] and IL-8 levels, and that in a variety of respiratory
cell lines and primary cell cultures, PCN stimulation
can cause the release of IL-8, IL-1 and IL-6 [5], accom-
panied by increased levels of IL-8 mRNA. PCN also
acts in synergy with IL-1α, IL-1β and TNF-α to induce
IL-8 expression in human airway epithelial cell lines
[6-8]. In contrast to its effects on IL-8 expression,
PCN inhibits cytokine-dependent expression of the
monocyte/macrophage/T-cell chemokine RANTES. It is
possible that the inhibition could cause inflammation of
mononuclear macrophage and T cell influx to subside.
Alveolar macrophages are significant defense cells and
inflammation regulatory cells which switch on multipli-
city mediators of inflammation and cytokines and then
cause acute lung injury. Although lung macrophages
have the capacity to participate in the host response to
P. aeruginosa, the role of alveolar macrophages in acute
P. aeruginosa infection has not been clearly defined. The
molecular mechanism by which these factors exert their
effects is poorly understood. Human medullary system
cell line U937 cells share characteristics with monoblasts
and pedomonocytes. The human U937 promonocytic
cell line was selected as the cell model since it is widely
used to study the differentiation of promonocytes into
monocyte-like cells [9-11]. Therefore, in this study, U937
cells were induced and differentiated into macrophages
with phorbol 12-myristate 13-acetate (PMA) and used to
study PCN effects on human macrophages.
Pseudomonas infections are characterized by a marked
influx of polymorphonuclear cells (PMNs) (neutrophils)
[12]. Increased release of IL-8, a potent neutrophil
chemoattractant, in response to PCN may contribute to
the marked infiltration of neutrophils and subsequent
neutrophil-mediated tissue damage that are observed in
Pseudomonas-associated lung diseases [7]. Previous stud-
ies by other investigators have identified a Pseudomonas
secretory factor with the properties of PCN that increases
IL-8 release by airway epithelial cells both in vitro [13]
and in vivo [14]. Based on these studies, we examined the
effect of PCN on IL-8 release in vitro using the human
monocyte model (PMA-differentiated human promonocy-
tic cell line U937) in synergy with inflammatory cytokines.
The reasons for specific focus on IL-8 and nuclear factor-
κB (NF-κB) pathway for IL-8 modulation are that IL-8 is
an established enhancer of neutrophil function [5,6,8],
while NF-κB is a transcription factor believed to play a key
role in IL-8 expression [15].Meanwhile, a number of studies have also shown that
the mitogen-activated protein kinases (MAPKs, including
ERK, JNK and p38) signal transduction pathways mediate
a variety of stimulating factors-induced IL-8 expression
[4,16-18]. NF-κB is a ubiquitous pleiotropic transcription
factor. Studies have shown that NF-κΒ activation is a con-
tributing factor for a variety of lung diseases and lung in-
flammation [19-21]. Pyrrolidine dithiocarbamate, a metal
chelator and antioxidant, can inhibit the activation of NF-
kB specifically by suppressing the release of the inhibitory
subunit Ik-B from the latent cytoplasmic form of NF-kB.
Recent studies have indicated that maximal IL-8 protein
expression requires activation of NF-κB as well as MAPKs
[17]. However, the precise relationship between NF-κB
transactivation and MAPK activation remains unclear. In
addition, few cellular pathways that are affected by PCN
are known. Hence, the present study was designed to test-
ify whether PCN can provoke the activation of macro-




RPMI-1640, fetal bovine serum (FBS), and antibiotics
were purchased from GIBCO BRL (Grand Island, NY).
Phospho-specific p38 MAPK and p38, and phospho-
specific ERK1/2 and ERK1/2 were from New England-
Biolabs (Bevely, MA). Stocks of the selective p38 MAPK
inhibitor SB203580, and stocks of the selective ERK1/2
inhibitor PD98059 were purchased from Calbio-chem-
Behring (Za Jolla, CA). Phospho-NF-κB p65 (Ser276)
antibody was purchased from Cell Signaling Technology
(CST, Danvers, MA) and anti-p-IκB-α (Ser32) from Santa
Cruz Biotechnology (Santa Cruz, CA) . IL-8 assay kit and
TNF-α were purchased from R&D Systems (Minneapolis,
MN). PMA was purchased from Merck Biosciences
(San Diego, CA). PMS (phenazinem ethosulfate, molecular
formula: C14H14N2O4S) was from AMRESCO (Solon, OH).
NF-κB inhibitor PDTC, PCN, N-acetylcysteine, LDH, SOD,
CAT, and MDA assay kits were purchased from Sigma
Chemical Co. (St. Louis, MO). All other reagents, unless
specified, were purchased from Sigma Chemical Co.
Cell culture and differentiation
U937 cells were purchased from ATCC (American Type
Culture Collection, Rockville, MD) and were cultured at
37°C in a humidified atmosphere with 5% CO2 in RPMI
1640 medium supplemented with 10% FCS and 50 μg/mL
gentamicin, which itself was supplemented with 4.5 g/L
glucose, 1 mM sodium pyruvate, and 10 mM HEPES. Cell
culture was maintained at a density of 1 × 106 cells/mL.
All cell lines were diluted one day before each experiment.
For differentiation into macrophages, U937 cells were
treated with PMA (10 nM) and allowed to adhere for 48 h
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they were washed and fed with PMA-free medium.
Treatment with PCN and inhibitors
PMA-differentiated U937 cells were washed and after-
wards different concentrations of PCN (5, 25, and
50 μM) were added into the medium and incubated for
24 h. Subsequently, the culture supernatant was col-
lected and stored at -70°C. IL-8 concentration was mea-
sured by enzyme-linked immunosorbent assay (ELISA)
assay. As a positive control, a separate group of PMA-
differentiated U937 cells was stimulated with TNF-α and
PCN. RNA was extracted afterwards, and IL-8 mRNA
levels were determined. In some experiments, SB203580,
PD98059 or PDTC was added into fresh medium of
U937 cells at 60 min before PCN incubation.
Thiazolyl blue tetrazolium bromide (MTT) assay
Cell viability was assessed using the MTT assay (Sigma)
according to the manufacturer’s instructions.
Measurement of IL-8
Cells were cultured in 24-well tissue culture plates until
they reached 80-90% confluence. Cells were cultured in
serum-free medium without growth factors and medium
supplements for 24 h prior to treatment. The medium
was harvested 24 h after treatment and stored at -20°C
until assayed. IL-8 level was determined by ELISA ac-
cording to the manufacturer’s instructions. The reprodu-
cibility, calculated as the coefficient of variation (CV),
was 5.5%.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from the U937 cells as de-
scribed by Chomczynski [22]. At the end of the incuba-
tion period, cells were washed with 1 mL ice-cold PBS
and solubilized with 1 mL of trizol. RNA was treated
with chloroform, centrifuged at 12000 × g for 15 min at
4°C and finally precipitated with ethanol. RNA was ex-
tracted and redissolved in diethylpyrocarbonate-treated
water, and the OD at 260 nm was used to determine its
concentration. To synthesize cDNA, 2.5 μg of RNA was
resuspended in a 10 μL final volume of the reaction buf-
fer and incubated for 30 min at 42°C. The reaction was
stopped by denaturing the enzyme at 95°C for 5 min.
Polymerase chain reaction was performed as follows.
Ten microliters of the synthesized cDNA were added to
40 μL of PCR mixture containing 5 μL of 5 × PCR buffer,
1 μL of primers (GenBank accession IL-8 sense: 5′-AGA
TGTCAGTGCATAAAGACA-3′, antisense: 5′-TGAAT
TCTCAG CCCTCTTCAAAAA-3′, 201 bp; GenBank ac-
cession β-actin sense: 5′-GGCATGGGTCAGAAGGATY
CC-3′, antisense: 5′-ATGTCACGCACGATTTCCCGC-
3′, 501 bp) and 0.25 μL DNA polymerase. PCR conditionsfor IL-8 were 35 cycles of denaturation at 94°C for 45 s,
annealing at 55.3°C for 45 s and extension at 72°C for
1 min. PCR conditions for β-actin were 35 cycles of de-
naturation at 94°C for 45 s, annealing at 59°C for 45 s
and extension at 72°C for 1 min. Amplified PCR prod-
ucts were separated by electrophoresis on 1.5% agarose
gel (UltraPure, Sigma) containing 0.05 μg/mL ethidium
bromide. The mRNA expression was visualized using a
Gel imaging system and analyzed using the molecular
analyst software and was standardized by the β-actin
housekeeping gene signal to correct any variability in
gel loading. The ratio between the optical density of β-
actin and the test gene was calculated to evaluate rela-
tive changes in the test gene.
Western blotting
The cytoplasmic and nuclear extracts from differentiated
U937 cells were prepared with NEPER Nuclear and
Cytoplasmic Extraction Reagents (Pierce, Rockford, IL).
Equal amounts (20 μg or 10 μg in the nuclear fraction)
of protein extracts were electrophoresed on 8–10% SDS
polyacrylamide gels and transferred onto polyvinylidene
difluoride membranes. Rabbit anti-phospho-p65 (Ser276)
and p-IκB-α (Ser32),rabbit anti- phospho-specific p38
MAPK and p38, rabbit anti-phospho-specific ERK1/2 and
ERK1/2 were used to detect the presence of phospho-p65,
phospho-specific p38 MAPK and p38; phosphor-specific
ERK1/2 and ERK1/2, respectively. The scanned figures
were visualized and quantified using Image J software.
Statistical analysis
Data presented are representative of 3-5 independent ex-
periments. Unless otherwise indicated, data were expressed
as means ± S.D. Data were analyzed using one-way analysis
of variance followed by LSD for multiple comparisons. Dif-
ferences were considered significant if p < 0.05. All analyses
were performed using SPSS 13.0 software.
Results
Induction of U937 cell differentiation by PMA
The U937 cells of a routine subculture are in the form of
a single cell suspension. After 8 h of culture in the pres-
ence of 10 nM PMA, the cells began to transform from
flat elongated suspension cells into irregular-shaped
amoeba-like cells that developed pseudopodia extensions
and adhered to the bottom of the container. After 48 h of
cultivation, 85% of the cells were adherent growth. So far,
differentiation of U937 cells by treatment with PMA has
been accomplished.
Cell viability assay
To assess the effect of PCN on cell viability, MTT assays
were performed on cells incubated with a range of PCN
concentrations (5-100 μM) after 24 h. Cell viability was
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5-6% was observed at a PCN concentration of 100 μM
(data not shown). Therefore, PCN concentrations ranging
from 5 to 50 μM was used in the subsequent experiments.
Effect of PCN on IL-8 mRNA
In these studies, TNF-α was used as a positive control to
further explore the expression of IL-8 mRNA induced
by PCN. After treatments with TNF-α (10 ng/mL) or
PCN (25 μM) alone or their combination for the indi-
cated periods, IL-8 mRNA levels were analyzed by RT-
PCR with its specific primers. PCN-mediated induction
of IL-8 mRNA in differentiated U937 cells was detectable
at any time point studied. TNF-α alone induced IL-8
mRNA in a time-dependent manner, which peaked at 2 h,
and stimulated IL-8 release in a concentration-dependent
manner after 24 hours of incubation (Figure 1). The
medium alone produced trace amounts of IL-8. Treat-
ment with PCN plus TNF-α slightly increased IL-8 mRNA
expression. This difference, however, was not statistically
significant (p > 0.05).
Induction of IL-8 release by PCN in PMA-differentiated
U937 cells
Previous studies have identified that PCN stimulates IL-
8 production by lung macrophage cells [23] and surface
epithelial cells [8,14,24]. Based on the physical properties
of PCN, we hypothesized that it was able to stimulate
differentiated U937 cells to produce IL-8. To test this
hypothesis, we exposed differentiated human U937 cells
to purified PCN and measured its effects on the release
of IL-8. After 24 hours of incubation with different con-
centrations of PCN (5 μM, 25 μM, or 50 μM) in PMA-
differentiated U937cells, the supernatants were collected
and IL-8 release detected by ELISA. The results showedFigure 1 The expression of IL-8 mRNA in PMA-differentiated U937 ce
treatments (TNF-α at 10 ng/mL and PCN at 25 μM and 25 μM PCN combin
analyzed by RT-PCR with specific primers for IL-8. Results shown are repres
quantified by densitometry, and standardized by the β-actin level. *p < 0.05
12-myristate 13-acetate.that PCN increased IL-8 release in differentiated U937
cells in a concentration-dependent manner. An increase
in IL-8 release was observed with PCN concentration at
as low as 5 μM and the concentration of 50 μM pro-
duced the strongest stimulation as to the cellular re-
sponse (Figure 2A and B). The increase in IL-8 above
control levels was observed at as early as 8 h after PCN
(50 μM) addition, and these levels continued to increase
between 24 h and 48 h (data not shown). Longer periods
of incubation were not tested.
The oxidative effect of PCN on differentiated U937 cells
A previous study has shown that PCN induces a
concentration-dependent loss of cellular glutathione
(GSH), an important cellular antioxidant, up to 50% in
the tissues infected by P. aeruginosa [25]. N-acetyl cyst-
eine (NAC) is the precursor of GSH. So we hypothesized
that NAC may play a protective role in cells exposed to
PCN. Thus, different concentrations of PCN (5, 25, and
50 μM) were added into differentiated U937 cells, and
the supernatants were collected after 24 hours. We then
detected the leakage of LDH, the content of MDA, and
the activities of SOD and CAT using their respective de-
tection kits. Results showed that the leakage of LDH and
the content of MDA increased and the activity of SOD
and CAT decreased, all in a dose-dependent manner.
There was a significant difference among the experimen-
tal groups (p < 0. 01) (Table 1). These results indicated
PCN can induce oxidative damage.
Effects of MAPK inhibitors on PCN-induced IL-8 release
A number of studies show that the MAPK signal trans-
duction pathways mediate IL-8 expressions induced by a
variety of stimulating factors [26]. We therefore went on
to explore the possibility that PCN may induce U937lls. RNA was extracted from PMA-differentiated U937 cells after various
ed 10 ng/mL TNF-α respectively) with the indicated time periods, and
entative of three separate experiments. Expression of IL-8 mRNA was
, **p < 0.01 compared with the level at 1 h or 2 h. PMA: phorbol
Figure 2 PCN increases IL-8 release in PMA-differentiated U937 cells. (A) Different concentrations of PCN (5 μM, 25 μM, or 50 μM) were
added to the cell cultures for 24 h. Supernatants were harvested for measuring IL-8 secretion by ELISA. (B) A fixed concentration of PCN (50 μM) was
added to the cell cultures for 8, 16 or 24 h. Supernatants were harvested for measuring IL-8 level by ELISA. Values represented are the mean ± SD of
four independent experiments in triplicate. **p < 0.01 compared with PMA-differentiated U937 cells. PMA: phorbol 12-myristate 13-acetate.
Table 1 The oxidative effect of pyocyanin on differentiated
U937 cells
(x ± s n=3)
Group LDH (U · L-1) MDA (mmol · L-1) SOD (Eu ·mL-1) CAT (Eu.mL-1)
C0 301 ± 48 0.91 ± 0.07 5.99 ± 0.96 1.86 ± 0.21
C1 521 ± 48** 2.01 ± 0.23** 4.66 ± 0.75* 1.27 ± 0.18*
C2 590 ± 52** 2.93 ± 0.19** 3.86 ± 0.62** 1.01 ± 0.14**
C3 668 ± 76** 3.85 ± 0.25** 3.12 ± 0.41** 0.62 ± 0.11**
Notice: C0: Control group; C1: PCN (5 μM); C2: PCN (25 μM); C3: PCN (50 μM).
*P< 0.05, compared with control; **P< 0.01, compared with control.
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experiments, different concentrations of the ERK and
P38 MAPK blockers (PD98059 at 10, 30, or 50 μM and
SB203580 at 10, 30, or 50 μM, respectively) were added
into the fresh medium of U937 cells 60 min before PCN
addition. After 24 hours, the supernatants were collected
and IL-8 concentrations were detected by ELISA. The
results showed that PD98059 and SB203580 significantly
decreased the secretion of IL-8, and as either substance’s
concentration increased, IL-8 secretion decreased, indi-
cating that PCN may stimulate U937 cells to express IL-
8 by both MAPK signaling pathways (Figure 3).
Effects of NF-κB inhibitor on PCN-induced IL-8 release
To further investigate whether NF-κB is involved in
PCN-induced IL-8 production, different concentrations
of NF-κB blockers (PDTC at 50, 100, or 200 μmol/L)
were added into fresh medium of PMA-differentiated
U937 cells 60 min before PCN was added. After 24 hours
of further incubation, the supernatants were collected
and IL-8 concentrations were detected. Results showed
that PDTC significantly decreased the secretion of IL-8,
and with increasing concentrations PDTC, IL-8 secre-
tion decreased, although in the presence of high concen-
trations of PCN, indicating that the PCN may stimulate
PMA-differentiated U937 cells to express IL-8 by NF-κB
signaling pathway (Figure 4).
Effect of antioxidant on PCN-induced IL-8 release
To further authenticate whether oxidative stress was in-
volved in PCN-induced IL-8 production and protective
role of NAC in cells exposed to PCN, different concen-
trations of NAC (5, 10, or 20 mmol/L) were added into
fresh medium of PMA-differentiated U937 cells 60 min
before PCN administration. After 24 hours of further in-
cubation, supernatants were collected and IL-8 concen-
trations were measured. The results showed that NAC
significantly decrease the secretion of IL-8, indicating apivotal role for oxidative stress in PCN-induced IL-8
expression in PMA-differentiated U937 cells (Figure 5).
Effects of MAPK and NF-κB inhibitors on PCN-induced
IL-8 mRNA
To determine whether activation of MAPK and NF-κB
mediates the PCN-dependent increase in IL-8 mRNA,
we tested the effects of several MAPK and NF-κB inhibi-
tors: SB203580 (a p38 inhibitor, 30 μM or 50 μM) and
PD98059 (an ERK1/2 inhibitor, 30 μM or 50 μM) or
PDTC (an NF-κB inhibitor, 200 μM). For these experi-
ments, cells were pretreated for 60 min with SB203580,
PD98059, or PDTC and then stimulated for 2 h with
50 μM PCN. The respective inhibitor was present
throughout the experiments. RNA was then isolated and
levels of mRNA were determined as described in materials
and methods. The results showed that all blockers used
can reduce the expression of IL-8 mRNA (Figure 6).
PCN increases phosphorylation of p38 and ERK1/2 MAPKs
To gain direct insights into PCN effect on MAPK acti-
vation, we then used PCN (50 μM) to stimulate U937
cells with or without pretreatment with MAPK inhibi-
tors (SB 20358 or PD98059, both at 30 μM) for 1 h.
Cellular protein was collected at 0, 10, 30, 60, and
Figure 3 MAPK inhibitors attenuate PCN-induced IL-8 release. Different concentrations of the ERK or P38MAPK blockers (PD98059 at 10, 30,
or 50 μM or SB203580 at 10, 30, or 50 μM) were added into fresh medium of PMA-differentiated U937 cells 60 min before PCN was added. Cells
were exposed to PCN (50 μM) for 24 h. Supernatants were harvested for measuring IL-8 by ELISA. **p < 0.01 compared with PMA-differentiated
U937 cells. MAPK: mitogen-activated protein kinase; ERK: extracellular signal-regulated kinase; PMA: phorbol 12-myristate 13-acetate.
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ERK activation after induction were assessed by West-
ern blotting using antibodies that specifically recognize
the phosphorylated forms of p38 and ERK MAPKs. Ac-
tive p38 was detected in PMA-differentiated U937 cells in-
duced by PCN, but the activation was transient, appearing
at 10 and 30 min and returned to baseline level after an-
other 30 min. Exposure of PMA-differentiated U937 cells
to PCN for 30 min reduced activation of ERK1/2. After
30 min of induction, activation of ERK1/2 began to re-
cover but then its activation was down-regulated in a
time-dependent manner, while the total ERK, p38MAPK
levels remained almost unchanged throughout the experi-
mental period (Figure 7).
PCN stimulated U937 cells to activate NF-κB
signaling pathway
Activation of the NF-κB signaling pathway is frequently
involved in the regulation of many immune response
and inflammatory genes [27]. To determine whetherFigure 4 NF-κB inhibitor reduces PCN-induced IL-8 release. Different c
added into fresh medium of PMA-differentiated U937 cells 60 min before P
(50 μM) for 24 h. Supernatants were harvested for measuring IL-8 by ELISA
12-myristate 13-acetate.PCN affects NF-κB signaling pathway, we examined the
effect of PCN treatment on a series of molecular events
that leads to NF-κB activation, including degradation
of I-κBα protein, translocation of p65 to the nucleus,
and the phosphorylation of p65. We used PCN
(50 μM) to stimulate PMA-differentiated U937 cells.
At 0, 10, 30, 60, 90, and 120 min, cell proteins were
collected and NF-κB p65 protein translocation was de-
tected by Western blotting. As shown in Figure 8,
within 10 min after addition of PCN, the level of p-I-
κBα in the cytosol was increased, which returned to
baseline level after 60 min. We further investigated the
change in nuclear localization of p65 protein. Within
10 min after addition of PCN, the level of p-p65 in
total cell lysate and cytosol was increased. There was
also an increase in the levels of p-p65 in the nuclear
extract, as evidenced by high levels of p-p65 which
persisted in total cell lysates (Figure 8). These results
suggest that PCN induces degradation of I-κBα and
subsequent translocation of NF-κB to the nucleus.oncentrations of NF-κB blocker (PDTC at 50, 100, or 200 μmol/L) were
CN was added. Cells were exposed to a fixed concentration of PCN
. *p < 0.05, **p < 0.01 compared with the PCN group. PMA: phorbol
Figure 5 Antioxidant can inhibit PCN-induced IL-8 release. Different concentrations of N-acetyl cysteine (NAC) (5, 10 or 20 mM) were added
into fresh medium of PMA-differentiated U937 cells for 60 min before PCN was added. After 24 h, supernatants were collected and IL-8
concentrations were detected by ELISA. *p <0.05, **p < 0.01 compared with the PCN groups. PMA: phorbol 12-myristate 13-acetate.
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signaling activation
To determine whether MAPKs mediate PCN-activated
NF-κB signaling pathway, we used PCN (50 μM) to
stimulate U937 cells with or without pretreatment with
MAPK and NF-κB inhibitors: SB 203580 (50 μM),
PD98059 (50 μM) and PDTC 200 μM for 1 h. Cell pro-
teins were collected at 30 min and NF-κB p65 protein
translocation was detected by Western blotting. The re-
sults showed that there was abundant cytosol distribu-
tion of NF-κB p65 before stimulation. All the indicated
blockers were able to reduce the localization of NF-κB
p65 in the cytosol (Figure 9). These data suggest that
SB203580 and PD98059 can effectively inhibit PCN-
induced NF-κB signaling activation. Therefore, it could
be concluded that the activation of p38 and ERK
MAPKs are signaling events that lie upstream of NF-κB
activation.Figure 6 MAPKs and NF-κB inhibitors can attenuate PCN-induced IL-8
SB203580 (30 μM or 50 μM), PD98059 (30 μM or 50 μM) or PDTC (200 μM)
throughout. RNA was then isolated, and levels of mRNA were determined.
by β-actin. *p < 0.05, **p < 0.01 compared with PCN. MAPK: mitogen-activatedDiscussion
The National Nosocomial Infection Surveillance indi-
cates that P. aeruginosa is the second most common
cause of nosocomial pneumonia after Staphylococcus
aureus [28]. Ventilator-associated pneumonia (VAP)
caused by P. aeruginosa is a severe complication of in-
tensive care, with mortality rates of 34 to 48% [28-30].
Therefore, it is critical to study the pathogenesis of P.
aeruginosa. In recent years, with the development of
technologies such as the gene chip and the protein chip,
and the clarification of the genome sequence of the P.
aeruginosa strain, it has been found that many elements
such as pro-inflammatory cytokines, antimicrobial pep-
tides, complements and epithelial cell receptors and
their signal transduction systems (TLR2, 4, 5, CFTR,
GM1, and its downstream NF-κB) participate in host
defense and immune response induced by P. aeruginosa.
It has also been found that P. aeruginosa componentsmRNA. PMA-differentiated U937 cells were pretreated for 60 min with
and then stimulated for 2 h with 50 μM PCN. Inhibitors were present
Expression of IL-8 mRNA was quantified by densitometry and standardized
protein kinase; PMA: phorbol 12-myristate 13-acetate.
Figure 7 The expression of phosphorylated and total MAPK proteins in PMA-differentiated U937 cells. PMA-differentiated U937 cells were
stimulated with PCN (50 μM) for the indicated time periods with or without pretreatment by MAPK inhibitor SB 203580 (30 μM) or PD98059
(30 μM ) for 1 h. (A and B) The expressions of phospho-ERK or ERK (A) and phospho-p38 or p38 (B). (C) The expression of phosphorylated and
total p38 and ERK proteins in U937 cells. Representative data of three independent experiments are shown. **p < 0.01 compared with the A
group; MAPK: mitogen-activated protein kinase; ERK: extracellular signal-regulated kinase; PMA: phorbol 12-myristate 13-acetate.
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density-sensing system, type secretion system, toxins, al-
ginate and cell toxin) play important roles in the patho-
genesis [2,16]. Among them, most P. aeruginosa strains
secrete PCN (N-methyl-1-hydroxyphenazine), the pig-
ment that gives blue-green color to the bacterial colonies
[4]. High concentrations of PCN are detected in pul-
monary secretions of patients with cystic fibrosis, where
it triggers inflammation, disrupts the bronchial epithe-
lium and impairs ciliary function. PCN also interferes
with the antioxidant defenses in the lung and facilitates
oxidative damage to the lung epithelium [31-35]. PCN
has been detected at concentrations as high as 100 μM
in pulmonary secretions from patients with P. aerugi-
nosa-associated airway disease [36], and its production is
increased when the organism is in the biofilm form[4,37]. Therefore, PCN plays an important role in acute
and chronic invasive infections.
Pseudomonas infections are characterized by a marked
influx of polymorphonuclear cells (PMNs) (neutrophils)
[12]. Activated PMNs release a variety of oxidants and
proteases that may contribute to the tissue injury that is
observed in Pseudomonas-infected airways [12,38]. Little
is known about the stimuli that are responsible for the
influx and activation of PMNs into the presence of this
bacterium. IL-8 is the major PMN chemoattractant re-
sponsible for PMN influx and activation in a variety of
disease states and thus likely plays an important role in
P. aeruginosa infections as well. It has been found that
culture supernatants and various purified secretion fac-
tors of P. aeruginosa such as pili protein, flagellin, self-
sensing materials, elastase, PCN and nitrite reductase
Figure 8 PCN activates NF-κB signaling pathway. Differentiated
U937 cells were stimulated with PCN (50 μM). At 0, 10, 30, 60, 90 and
120 min, cell proteins were collected. Cytosolic or nuclear protein was
extracted, and Western blotting was performed to detect NF-κB p65
protein translocation. Levels of phospho-p65 (Ser276) in whole cell
lysates (A), cytosol (B) or nuclear contents (C) were examined by
Western blot analysis with the respective antibodies. Levels of p65
was also determined in nuclear fractions. β-actin was used as a
control for equal loading. Data are the summary of averaged relative
density units measured in 3 independent experiments. *p < 0.05
compared with control.
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lial cells, primary bronchial gland epithelial cells both
in vivo and in vitro [40]. It was found that with NF-κB
activation, rapid and sustained IL-8 mRNA expression
was induced [37].
Recent studies have also further confirmed that in a
variety of respiratory cell lines and primary cultures of
cells, PCN stimulation can cause the release of IL-8, ac-
companied by increased IL-8 mRNA expression. PCN
also acts in synergy with IL-1α, IL-1β and TNF-α toFigure 9 Effects of MAPK inhibitors on PCN-induced NF-κB
signaling pathway. U937 cells were stimulated with PCN at 50 μM
for the time periods indicated with or without pretreatment by
MAPK and NF-κB inhibitors: SB 203580 (50 μM), PD98059 (50 μM)
and PDTC (200 μM) for 1 h. Cell proteins were then collected and
NF-κB p65 protein expression was detected with Western blotting.induce IL-8 expression [5,6,8]. After PCN was injected
into animals and the respiratory tracts, bronchial lavage
fluid and neutrophil (PMN) levels were increased signifi-
cantly [41]. However, there are few reports on PCN ef-
fect on macrophages.
Our experimental results show that PCN induced ex-
pression of IL-8 in PMA-differentiated U937 cells, as
well as IL-8 protein secretion and mRNA expression in
a concentration- and time- dependent manner. It is also
found that PCN synergizes with TNF-α to induce the ex-
pression of IL-8 in PMA-differentiated U937 cells. So
far, most studies only observe the pro-inflammatory ef-
fects of the P. aeruginosa bacterial products on epithelial
cells and macrophages, and their effects on U937 cells
are less than well defined. The present study extends
these findings by demonstrating that MAPKs and NF-κB
signalings lie behind PCN-induced IL-8 production in
differentiated U937 cells.
The MAPK family has an important role in signal trans-
duction, and the pathway is activated by a variety of stim-
uli such as growth factors and cellular stresses [42,43].
Activated MAPKs can regulate the expression of inflam-
matory cytokines. In mammalian cells, it has been found
that there are at least three major MAP kinase (MAPK)
pathways including the extracellular signal-regulated kin-
ase pathway (ERK), c-Jun N-terminal kinase/stress-acti-
vated protein kinase pathway (JNK), and the P38 MAPK
pathway. A unique feature of the MAPKs is that they be-
come activated after phosphorylation of both their tyro-
sine and threonine amino acids [44]. They are different
activated extracellular signals that produce different bio-
logical effects. It has been found that MAPKs can modu-
late the expression of IL-8 in human peripheral blood
mononuclear cells, granulocytes, mast cells, intestinal epi-
thelial cells, and pulmonary vascular endothelial cells and
that the use of P38 inhibitors can reduce the IL-8 mRNA
and protein expression [19,23,41,45].
We used PCN to stimulate PMA-differentiated U937
cells and found that PCN could induce ERK and P38
MAPK protein phosphorylation, thus indicating the pos-
sible participation of ERK and p38 MAPK pathways in
the regulation of IL-8. Our further investigation using
MAPK pathway inhibitors PD98059 and SB203580 dem-
onstrated that they may partially inhibit the phosphoryl-
ation and reduce IL-8 synthesis induced by PCN in a
concentration-dependent manner, indicating that PCN
may stimulate PMA-differentiated U937 cells to express
cytokine IL-8 by MAPK signaling pathways.
NF-κB is a ubiquitous pleiotropic transcription factor,
and studies have shown that NF-κΒ activation is critically
involved in a variety of lung diseases and lung inflamma-
tion [19-21]. NF-κB activation can regulate a series of lung
gene expression related to inflammatory and immune re-
sponses: pro-inflammatory cytokines such as TNF-α, IL-
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Therefore, its activity is closely related with acute lung in-
jury (ALI) and acute respiratory distress syndrome
(ARDS) [46]. In most cell types, NF-kB is retained usually
in the cytoplasm of the unstimulated cells by I-kBα family
proteins. Upon stimulation, the I-kBα kinase complex is
activated, resulting in the phosphorylation of I-kBs [47,48]
The phosphorylated IkBs are ubiquitinated and subse-
quently degraded, which will release the transcription fac-
tor NF-kB [36,37]. In this study, we also found that PCN
stimulation was associated with a significant increase in
the level of phosphorylated I-kBα in total cell lysates. We
further demonstrated that I-kBα decrease was accompan-
ied by increased nuclear localization of p65 protein. These
results suggest that PCN induces degradation of I-κBα
and the subsequent translocation of NF-κB to the nucleus.
The results also showed that different blockers (SB203580,
PD98059 and PDTC) can reduce the expression of NF-κB
p65 expression in cytosol and IL-8 expression, indicating
that PCN may stimulate PMA-differentiated U937 cells to
express cytokines IL-8 by MAPK and NF-κB signaling
pathways.
Acute and chronic pulmonary infection with P. aerugi-
nosa is associated with an intense neutrophil inflamma-
tory response that contributes to lung injury [49]. A
previous study has shown that PCN enhances airway epi-
thelial cell release of IL-8 [4], a neutrophil chemokine
whose production is regulated by oxidant-sensitive tran-
scription factors [50,51]. Our data indicated that PCN
could induce oxidative damage in U937 cells and antioxi-
dant NAC inhibited PCN-induced IL-8 protein expres-
sion. In most cases, PCN’s cytotoxicity has been strongly
linked to its potential effects on redox cycle. When enter-
ing into cells, PCN oxidizes intracellular pools of NADPH,
NADH and GSH directly by accepting electrons, and it
passes these electrons to oxygen leading to sustained gen-
eration of ROS (O2
_ and H2O2) under aerobic condition
[25]. Oxidative damage results in unbalance between the
oxidant and antioxidant processes. Antioxidant defense
system (enzymatic scavengers SOD, CAT and so on and
some smal1 molecule antioxidants including NAC, GSH,
vitamin C and vitamin E) plays an important role in the
elimination of oxygen radical [52]. Cellular GSH levels
have been reported to influence the activity of a number
of transcription factors, including NF-κB, AP-1, and HIF-
1α [53,54]. NAC is a thiol compound that has direct anti-
oxidant properties and also is converted to GSH by cells
and thereby limits oxidant-mediated cell injury. By dem-
onstrating the inhibitory effect of NAC on PCN-induced
IL-8 production, we indicate that NAC can act as a pro-
tective factor that mitigates PCN pro-inflammatory effect
on differentiated U937 cells.
In short, in this study, we found that PCN could in-
duce PMA-differentiated U937 cells to produce IL-8 byactivating MAPKs and NF-κB signaling pathways. Our
further studies will focus on understanding the inter-
action between p38 MAPK, ERK and other cytokine reg-
ulators. Knowledge of the mechanisms by which PCN
induces PMA-differentiated U937 cells to produce cyto-
kines may provide better understanding and rational ap-
proaches for the control of PCN-induced inflammatory
processes.
Conclusions
PCN induces U937 cells in a concentration- and time-
dependent manner to increase IL-8 mRNA expression
and secretion. Furthermore, MAPKs and NF-κΒ signal-
ing pathways may be involved in the expression of IL-8
in PCN-exposed U937 cells, indicating that the green
pus streptozotocin in the P.aeruginosa infection has an
important role in inflammation reactions. PCN or TNF-
α alone could induce PMA-differentiated U937 cells to
express IL-8, but no synergistic effect was observed be-
tween these two factors. The mechanism requires fur-
ther study.
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